全文获取类型
收费全文 | 254篇 |
免费 | 3篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 2篇 |
妇产科学 | 4篇 |
基础医学 | 12篇 |
口腔科学 | 9篇 |
临床医学 | 11篇 |
内科学 | 9篇 |
皮肤病学 | 2篇 |
神经病学 | 6篇 |
特种医学 | 19篇 |
外科学 | 118篇 |
综合类 | 26篇 |
预防医学 | 1篇 |
眼科学 | 22篇 |
药学 | 9篇 |
中国医学 | 1篇 |
肿瘤学 | 5篇 |
出版年
2023年 | 3篇 |
2022年 | 5篇 |
2021年 | 11篇 |
2020年 | 5篇 |
2019年 | 10篇 |
2018年 | 6篇 |
2017年 | 8篇 |
2016年 | 6篇 |
2015年 | 9篇 |
2014年 | 13篇 |
2013年 | 14篇 |
2012年 | 8篇 |
2011年 | 11篇 |
2010年 | 15篇 |
2009年 | 9篇 |
2008年 | 11篇 |
2007年 | 11篇 |
2006年 | 7篇 |
2005年 | 16篇 |
2004年 | 10篇 |
2003年 | 15篇 |
2002年 | 12篇 |
2001年 | 10篇 |
2000年 | 8篇 |
1999年 | 4篇 |
1998年 | 2篇 |
1996年 | 5篇 |
1995年 | 2篇 |
1994年 | 1篇 |
1993年 | 3篇 |
1992年 | 3篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1986年 | 2篇 |
1977年 | 1篇 |
排序方式: 共有259条查询结果,搜索用时 15 毫秒
1.
2.
上肢骨肿瘤切除后的自体骨移植重建 总被引:1,自引:0,他引:1
目的探讨应用自体骨移植对上肢骨肿瘤切除后的骨缺损修复重建的效果。方法1998年8月~2004年3月,收治上肢骨肿瘤切除后的骨缺损16例。男8例,女8例。年龄7~45岁。经病理确诊,肱骨近端尤文肉瘤和骨肉瘤各1例;肱骨远端尤文肉瘤2例;桡骨远端骨巨细胞瘤8例,高分化软骨肉瘤2例,恶性纤维组织细胞瘤和骨肉瘤各1例。2例肱骨近端肿瘤行自体锁骨代肱骨;2例肱骨远端肿瘤行自体腓骨代肱骨;12例桡骨远端肿瘤中,1例行自体髂骨移植,11例行自体腓骨代桡骨进行重建。采用MSTS系统进行术后功能评价。结果2例肱骨近端自体锁骨移植患者分别随访36个月和12个月,术后保持部分肩关节前屈和后伸功能,但外展功能丧失;MSTS评分分别为23分和22分。2例肱骨远端自体腓骨移植患者分别随访4个月和6个月,肘关节功能良好,移植骨连接处已经出现骨愈合;MSTS功能评分分别为24分和19分。12例桡骨远端自体骨移植患者中11例随访6~75个月,功能良好,无明显并发症;1例髂骨植骨的桡骨远端骨巨细胞瘤术后3个月移植骨完全愈合,至今随访75个月,肿瘤无复发。MSTS功能评分18~27分,平均22.6分。结论自体骨移植在上肢骨肿瘤切除后骨缺损的重建,尤其是儿童的骨缺损重建中,是一种较好的方法。 相似文献
3.
H Kienapfel D R Sumner T M Turner R M Urban J O Galante 《Journal of orthopaedic research》1992,10(3):423-433
Autogenous cancellous bone and freeze-dried allogeneic cancellous bone were tested in a total of 41 adult male mongrel dogs. In each humerus, an implant with a commercially pure titanium fiber metal porous coating was placed in an overreamed cavity so that a uniform 3-mm gap was present between the implant and host cancellous bone. Graft material was placed in the gap of one humerus while the gap of the other humerus was left empty and served as a paired negative control. Histologically, both autograft and allograft appeared to aid repair of the defect, but quantitatively only autograft enhanced new bone formation within the defect. Treatment with autograft significantly increased the amount of bone ingrowth within the implants by nearly three-fold at 4 weeks and eight-fold at 8 weeks. The enhancing effect was recognizable as early as 2 weeks. The strength of fixation was increased by nearly seven-fold at 4 weeks and two-fold at 8 weeks in the autograft group, but this was only statistically significant at 4 weeks. Treatment with allograft did not enhance bone ingrowth at any time period, but had a small positive effect on strength of fixation at 4 weeks. 相似文献
4.
目的探讨碱性成纤维细胞生长因子(bFGF)反义寡核苷酸对大鼠自体移植静脉内膜增生的影响。方法 Wistar大鼠48只,分为反义寡核苷酸(AODN)组、正义寡核苷酸(SODN)组、随机寡核苷酸(RODN)组、空白对照组。将含300μg寡核苷酸的F127多聚凝胶溶液涂于移植静脉及吻合口外周,对比术后1周、2周移植静脉平均内膜及中膜厚度。并检测血管壁细胞内bFGF蛋白表达。结果术后1周、2周,AODN组内膜厚度、内膜/中膜及bFGF阳性细胞率均小于其它各组,差异均有显著性(P<0.05)。而SODN组、RODN组,空白对照组之间比较,均无显著性差异(P>0.05)。术后2周,SODN组、RODN组、空白对照组内膜增生较术后1周时明显,差异有显著性(P<0.05)。结论 bFGF反义寡核苷酸通过对bFGF基因表达的抑制作用,达到了抑制移植静脉内膜增生的目的 。 相似文献
5.
6.
《Burns : journal of the International Society for Burn Injuries》2021,47(5):1066-1073
Reducing the amount of donor skin needed for definitive wound closure can improve outcomes in patients with severe burns. This Delphi Consensus Panel (DCP) aimed to achieve expert consensus on the percentage reduction in donor skin for autograft that constitutes a clinically meaningful benefit. A two-round DCP of fifteen US burn surgeons was conducted via a web-based survey platform. Fourteen panelists (93.3%) completed both rounds. In Round 2, consensus, defined as ≥70% agreement, was achieved for five of the seven consensus statements. All panelists agreed that a clinically meaningful reduction in the amount of donor skin required would facilitate wound management and decrease donor site morbidity experienced by patients. Furthermore, based on three treatment scenarios, consensus was achieved for a clinically meaningful reduction in the amount of donor skin required for autograft for the adult population in deep partial-thickness and full-thickness burns. Findings from this DCP indicate that an innovative cellular and/or tissue product that would reduce the needed amount of donor skin, by the identified thresholds, has the potential to improve the outcomes for patients with severe burn injuries in a meaningful way. 相似文献
7.
8.
9.
10.